
Sign up to save your podcasts
Or


Johnson & Johnson posts strong 2nd-quarter results and raises guidance for the full fiscal year. Philip Morris has a mixed 2nd-quarter and gets questions about its recent acquisition. Sarah Gentry and Connor Allen analyze those stories, pick out highlights from Netflix’s most recent results, and share why Blue Bird Corp. and DermTech are on their watchlists.
Looking for even more stocks to put on your watchlist? Get 50% off our Stock Advisor service by going to http://StockIdeas.fool.com.
By The Motley Fool4.7
16041,604 ratings
Johnson & Johnson posts strong 2nd-quarter results and raises guidance for the full fiscal year. Philip Morris has a mixed 2nd-quarter and gets questions about its recent acquisition. Sarah Gentry and Connor Allen analyze those stories, pick out highlights from Netflix’s most recent results, and share why Blue Bird Corp. and DermTech are on their watchlists.
Looking for even more stocks to put on your watchlist? Get 50% off our Stock Advisor service by going to http://StockIdeas.fool.com.

3,220 Listeners

1,710 Listeners

806 Listeners

942 Listeners

515 Listeners

4,359 Listeners

1,630 Listeners

825 Listeners

5,128 Listeners

675 Listeners

9,516 Listeners

1,030 Listeners

341 Listeners

304 Listeners

1,289 Listeners

1,553 Listeners

81 Listeners